Gao X - Search Results

1

Gene delivery of medium chain acyl-coenzyme A dehydrogenase induces physiological cardiac hypertrophy and protects against pathological remodelling.

Bernardo BC, Weeks KL, Pongsukwechkul T, Gao X, Kiriazis H, Cemerlang N, Boey EJH, Tham YK, Johnson CJ, Qian H, Du XJ, Gregorevic P, McMullen JR. Bernardo BC, et al. Among authors: gao x. Clin Sci (Lond). 2018 Feb 8;132(3):381-397. doi: 10.1042/CS20171269. Print 2018 Feb 14. Clin Sci (Lond). 2018. PMID: 29358507

2

Lipidomic Profiles of the Heart and Circulation in Response to Exercise versus Cardiac Pathology: A Resource of Potential Biomarkers and Drug Targets.

Tham YK, Bernardo BC, Huynh K, Ooi JYY, Gao XM, Kiriazis H, Giles C, Meikle PJ, McMullen JR. Tham YK, et al. Cell Rep. 2018 Sep 4;24(10):2757-2772. doi: 10.1016/j.celrep.2018.08.017. Cell Rep. 2018. PMID: 30184508 Free article.

3

Phosphoinositide 3-kinase p110α is a master regulator of exercise-induced cardioprotection and PI3K gene therapy rescues cardiac dysfunction.

Weeks KL, Gao X, Du XJ, Boey EJ, Matsumoto A, Bernardo BC, Kiriazis H, Cemerlang N, Tan JW, Tham YK, Franke TF, Qian H, Bogoyevitch MA, Woodcock EA, Febbraio MA, Gregorevic P, McMullen JR. Weeks KL, et al. Among authors: gao x. Circ Heart Fail. 2012 Jul 1;5(4):523-34. doi: 10.1161/CIRCHEARTFAILURE.112.966622. Epub 2012 Jun 15. Circ Heart Fail. 2012. PMID: 22705768

4

Therapeutic silencing of miR-652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophy.

Bernardo BC, Nguyen SS, Winbanks CE, Gao XM, Boey EJ, Tham YK, Kiriazis H, Ooi JY, Porrello ER, Igoor S, Thomas CJ, Gregorevic P, Lin RC, Du XJ, McMullen JR. Bernardo BC, et al. FASEB J. 2014 Dec;28(12):5097-110. doi: 10.1096/fj.14-253856. Epub 2014 Aug 21. FASEB J. 2014. PMID: 25145628

5

Inhibition of miR-154 Protects Against Cardiac Dysfunction and Fibrosis in a Mouse Model of Pressure Overload.

Bernardo BC, Nguyen SS, Gao XM, Tham YK, Ooi JY, Patterson NL, Kiriazis H, Su Y, Thomas CJ, Lin RC, Du XJ, McMullen JR. Bernardo BC, et al. Sci Rep. 2016 Mar 1;6:22442. doi: 10.1038/srep22442. Sci Rep. 2016. PMID: 26928825 Free PMC article.

6

Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis.

Gao XM, Wong G, Wang B, Kiriazis H, Moore XL, Su YD, Dart A, Du XJ. Gao XM, et al. J Hypertens. 2006 Aug;24(8):1663-70. doi: 10.1097/01.hjh.0000239304.01496.83. J Hypertens. 2006. PMID: 16877971

7

Down-regulation of mitofusin-2 expression in cardiac hypertrophy in vitro and in vivo.

Fang L, Moore XL, Gao XM, Dart AM, Lim YL, Du XJ. Fang L, et al. Life Sci. 2007 May 16;80(23):2154-2160. doi: 10.1016/j.lfs.2007.04.003. Epub 2007 Apr 21. Life Sci. 2007. PMID: 17499311

8

Endogenous relaxin does not affect chronic pressure overload-induced cardiac hypertrophy and fibrosis.

Xu Q, Lekgabe ED, Gao XM, Ming Z, Tregear GW, Dart AM, Bathgate RA, Samuel CS, Du XJ. Xu Q, et al. Endocrinology. 2008 Feb;149(2):476-82. doi: 10.1210/en.2007-1220. Epub 2007 Nov 8. Endocrinology. 2008. PMID: 17991721

9

Higher levels of collagen and facilitated healing protect against ventricular rupture following myocardial infarction.

Fang L, Gao XM, Samuel CS, Su Y, Lim YL, Dart AM, Du XJ. Fang L, et al. Clin Sci (Lond). 2008 Aug;115(3):99-106. doi: 10.1042/CS20070365. Clin Sci (Lond). 2008. PMID: 18248324

10

Reversal of cardiac fibrosis and related dysfunction by relaxin.

Du XJ, Xu Q, Lekgabe E, Gao XM, Kiriazis H, Moore XL, Dart AM, Tregear GW, Bathgate RA, Samuel CS. Du XJ, et al. Ann N Y Acad Sci. 2009 Apr;1160:278-84. doi: 10.1111/j.1749-6632.2008.03780.x. Ann N Y Acad Sci. 2009. PMID: 19416203

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28,622 results

Search Page

Filters